Home > Boards > US Listed > Biotechs >

Jazz Pharmaceuticals (JAZZ)

Add JAZZ Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 3/7/2021 7:45:35 PM - Followers: 14 - Board type: Free - Posts Today: 0

Jazz Pharmaceuticals plc is a dynamic specialty biopharmaceutical company that identifies, develops and commercializes innovative products to address unmet medical needs in focused therapeutic areas, always keeping in mind our mission to improve patients' lives. Living our core values of integrity, passion, collaboration, innovation and the pursuit of excellence is the key to our success.



Our mission is to improve patients' lives by identifying, developing and commercializing important specialty pharmaceutical products to address unmet patient needs. We address serious diseases, always with the goal of improving patient care. Keeping patients at the forefront of our mind inspires us to bring innovative and valuable resources to all aspects of our business for the ultimate benefit of the patients in need.


Our core values define our corporate practices and demonstrate our commitment to improving patients' lives.


We value honesty and compliance with all of the laws, rules, regulations and corporate policies that apply to our business, and we expect the same total commitment from our employees, consultants, business partners and service providers. We view our uncompromising commitment to honesty and compliance as a core value - one that we look for in all of our employees.


Like the talented musicians who inspired our company name, we believe that the whole is much greater than the sum of its parts. Jazz musicians are known for working together to create new and exciting riffs or new variations on familiar themes. Similarly, the hallmark of our collaborative spirit is our ability to work together in creative teams to accomplish not only research and development goals, but also commercial and corporate objectives. Our value of and respect for one another support our collaboration on projects to help patients, patient advocates and our community.


Our passion is our unwavering commitment to improving patient care. The intensity we devote to our efforts and our focus on the efficient development of products to address unmet patient needs are clear evidence of our passion.


Innovation is essential to help patients and health care providers address unmet medical needs. Striving to provide new benefits for unmet patient needs requires us to look for novel solutions, particularly where others have been discouraged by the difficulty of the problem or the small size of the patient population.


In all that we do - our passion and collaboration, our integrity and our caring for patients - we demonstrate our pursuit of excellence. We will always strive to take it to the next level.


The name "Jazz Pharmaceuticals" was inspired by the talented jazz musicians who come together - each a musical specialist with an individual style - to make music in concert that is greater than the sum of its parts. Jazz musicians are known for working together to create new and exciting riffs or new variations on familiar themes. Jazz music showcases the coexistence of improvisation and structure.

At Jazz Pharmaceuticals, we believe that each member of our team makes integral contributions working toward a common goal to improve patients' lives. The hallmark of our collaborative spirit is our ability to work together in creative teams to accomplish not only research and development goals, but also commercial and corporate objectives.


At Jazz Pharmaceuticals, our mission is to improve patients' lives by identifying, developing and commercializing products including: XYREM, ERWINAZE, PRIALT, FAZACLO LD and HD and LUVOX CR. The product information on XYREM, ERWINAZE, PRIALT, FAZACLO LD and HD and LUVOX CR is intended only for residents of the United States. Click on the logos below to view complete prescribing information, including boxed warnings.

In addition to these products marketed in the U.S., EUSA Pharma, an international division of Jazz Pharmaceuticals, markets products outside of the U.S. in more than 80 countries. For more information please visit: www.EUSAPharma.com.

To report an adverse event or a product complaint, or to request information about our products, please click here.



Jazz Pharmaceuticals has an unwavering commitment to improving care for patients with serious medical conditions through innovative treatments. We are working to expand our current portfolio of commercial products through targeted investments in post-discovery research and development. We are working closely with healthcare professionals and patient advocates to identify significant treatment gaps where Jazz Pharmaceuticals' approach to patient care may be able to help solve problems in a unique way that will make a substantive difference for patients.

Our long-term vision includes building a development pipeline that could offer potential new treatment options for patients. Our current research and development efforts include programs to improve the current products in our oncology and psychiatry franchises, as well as other development opportunities that support our mission to improve patient's lives.



(asparaginase Erwinia

  • IV formulation in development
  • Exploring additional labeling opportunities



  • Anti-CD25 monoclonal antibody
  • Treatment of steroid-refractory acute graft vs. host disease
  • EU Phase III study underway



  • Pegylated recombinant erwinia asparaginase
  • E. Coli asparaginase hypersensitivity
  • Currently in Phase I development in EU


  • Oral dosing formulation, for which an NDA has been submitted to
    the FDA
  • Additional formulations to provide potential new dosing options to patients and physicians
  • Once daily formulation undergoing evaluation



Fourth Floor, Connaught House,
One Burlington Road, Dublin 4,
Phone: +353.1.634.7800
Fax: +353.1.634.7850

3180 Porter Drive
Palo Alto, CA 94304
Phone: 650.496.3777
Fax: 650.496.3781

1818 Market Street, Suite 2350
Philadelphia, PA 19103
Phone: 215.832.3750
Fax: 215.832.3789

One Summit Square
1717 Langhorne-Newtown Road
Suite 201
Langhorne, PA 19047
Phone: 215.867.4900
Fax: 215.579.0384

EUSA Pharma International Headquarters
Oxford UK office
The Magdalen Centre
Oxford Science Park
Oxford, OX4 4GA


Firm Analyst
Bank of America Merrill Lynch Gregg Gilbert
Barclays Capital Douglas Tsao
Brean Murray Carret & Co. Gene Mack
Cantor Fitzgerald Irina Rivkind
Citi Jonathan Eckard, Ph.D.
Cowen & Co. Ken  Cacciatore
Discern Patricia Bank
Guggenheim Louise Chen
Jefferies & Company Corey Davis, Ph.D.
Lazard Capital Markets William Tanner, Ph.D.
Leerink Swann Michael Schmidt, Ph.D.
Oppenheimer Christopher Holterhoff
Piper Jaffray David Amsellem
UBS Ami Fadia
Wallach Beth Capital, LLC Difei  Yang, Ph.D.

Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
JAZZ News: Statement of Changes in Beneficial Ownership (4) 05/07/2021 04:46:48 PM
JAZZ News: Initial Statement of Beneficial Ownership (3) 05/07/2021 04:24:41 PM
JAZZ News: Securities Registration: Employee Benefit Plan (s-8) 05/07/2021 04:03:34 PM
JAZZ News: Statement of Changes in Beneficial Ownership (4) 05/05/2021 07:04:02 PM
JAZZ News: Current Report Filing (8-k) 05/05/2021 04:11:52 PM
News News Alert: Statement of Changes in Beneficial Ownership (4) 05/07/2021 04:46:48 PM
#264   Just watching on "60 Minutes" about Fluvoximine Maleate Chuxster 03/07/21 07:45:35 PM
#263   BREAKING NEWS: $JAZZ Jazz Pharmaceuticals Announces Positive Top-line whytestocks 10/08/20 11:45:25 PM
#262   They need Coca Cola cake industry for air lucmariepierre 04/22/20 11:39:17 AM
#261   I think blueberries are the best treatment for lucmariepierre 07/06/19 12:38:14 AM
#260   News: $JAZZ Jazz Pharmaceuticals Data to Showcase Ongoing whytestocks 05/09/19 08:20:35 AM
#259   Did you try astragale Japanese tea and pissenlit instead lucmariepierre 04/11/19 02:29:01 PM
#258   Did you try or try Marjolaine and mélisse lucmariepierre 03/09/17 11:07:32 AM
#257   Owc$ following same path can't believe jazz use xfrozenx 02/23/17 09:45:14 PM
#256   Jazz Pharmaceuticals to Report 2016 Fourth Quarter and queenofjill 02/15/17 04:32:35 PM
#255   Nice low floater here. Biotech is coming back here HiddenGem69 11/04/16 09:21:35 PM
#254   I think jazz products aren't as good as lucmariepierre 09/18/16 03:42:39 PM
#253   JAZZ always has delayed response to such news. 955 08/26/16 04:36:21 PM
#252   Why the stock is in dépressive mood I thought lucmariepierre 08/17/16 12:56:08 PM
#251   Nice! europtiger 07/28/16 02:58:58 PM
#250   JAZZ D TREND1 06/16/15 03:12:56 PM
#249   Looking back on JAZZ board. Trying to figure tpizzazz24 05/23/15 02:55:06 AM
#248   Support level hit today...let's see if it holds....wouldn't Lotto123 02/04/15 06:49:07 PM
#247   Back to playing JAZZ on small swings.... rock Lotto123 02/04/15 06:45:12 PM
#246   Got spoiled riding this puppy from the celler....topped Lotto123 02/04/15 06:43:59 PM
#245   Love that pop in Jan....need a rumor of Lotto123 02/04/15 06:43:14 PM
#244   *DJ Jazz Pharmaceuticals: Phase 1 Clinical Data Generated UserAlias1 12/09/14 08:36:50 AM
#243   $JAZZ NEWS: Jazz Pharmaceuticals and Concert Pharmaceuticals Provide UserAlias1 12/09/14 08:34:05 AM
#242   $JAZZ Cantor Raises Jazz Pharmaceuticals Price Target On maytepper 11/03/14 11:12:05 AM
#241   I am told JAZZ is turned out to Setay 11/02/14 05:50:26 AM
#240   For some reason I am very partial to jazz_1 10/16/14 03:03:17 PM
#239   $JAZZ $FLML Canaccord Provides Input Into Jazz’s Patent maytepper 10/03/14 05:25:03 PM
#238   Loved it entered with entered fri the $165.00 Skitradr 09/10/14 09:26:05 AM
#237   Got out of this Monday when she hit 171... Skitradr 09/10/14 09:22:21 AM
#235   lolzzz, I really did use it a lot Lotto123 09/05/14 10:46:59 PM
#234   That's funny.......just found one of you're old post Skitradr 09/05/14 09:55:22 PM
#233   Buy point at $165+....nice..... dammmm, I haven't done Lotto123 09/05/14 09:43:54 PM
#232   This sure doesn't hurt the cause ....... Skitradr 09/05/14 09:27:10 PM
#231   Nice ......this one's been very nice to me Lotto123 09/05/14 08:37:04 PM
#230   I agree.....picked up some sept 20th $ 165.00 Skitradr 09/05/14 07:59:54 PM
#229   JAZZ Nice day....weeeeeeeeeeeeeeeeeeeee... Lotto123 09/05/14 07:27:34 PM
#228   You still holding this treasure? :-) Lotto123 08/29/14 05:39:24 PM
#227   Double top or breakout coming... ;-) Lotto123 08/29/14 05:36:39 PM
#226   JAZZ crankin' again... weeeeeeeeeeeeee... Lotto123 08/29/14 05:06:33 PM
#225   JAZZ - My personal gift from God... :-D Lotto123 08/20/14 08:59:06 AM
#224   Cantor Fitzgerald Reiterates Hold On Jazz Pharmaceuticals Following maytepper 08/08/14 11:42:43 AM
#223   AMBS is a Sham... Look at the BS expediter13 07/21/14 06:54:13 AM
#222   Ripe for inversion....cheap price considering... Lotto123 06/28/14 12:24:51 AM
#221   WSJ: http://blogs.wsj.com/pharmalot/2014/06/20/a-look-at-the-european-pharmaceut Lotto123 06/28/14 12:20:46 AM
#220   Triggered out on dip...Loading back up first sign.. ;-) Lotto123 06/28/14 12:05:58 AM
#219   LOLZZZZZZ....Not sure who is still around....I loaded up Lotto123 06/19/14 11:56:27 PM
#217   Just curious. I am from another board (almost longboardsurfer90210 06/01/14 03:40:54 PM
#216   lol, funny to read old comments like this JojoK 05/25/14 12:18:22 AM
#215   $JAZZ: Broke below Major Support..... bsdvs23 04/29/14 07:29:12 AM
#214   $JAZZ: Could be intraday topping here.... bsdvs23 04/07/14 02:45:49 PM
#213   $JAZZ: Continuing its Lower Highs and Lower Lows..... bsdvs23 04/07/14 12:05:05 PM
Consent Preferences